If you only want the short version. For one family of compounds the timing advice has real physiology behind it. For everything else it is invented.
The growth hormone peptides are the exception. Your own growth hormone is released mostly at night, and food suppresses that release, which is why the advice to dose at night on an empty stomach is one of the few community rules with published work underneath it.
One detail in that advice is wrong. People avoid carbohydrates before dosing. In a controlled study, a high-fat meal suppressed the growth hormone response more than a high-glucose one did.
For the weekly GLP-1 drugs, the day you inject is an adherence question and not a pharmacological one. For BPC-157, TB-500 and most of the rest, no study has compared one time of day with another.
Half-life decides whether timing matters at all
Before any of the physiology, one property settles how much the question applies to you.
Half-life is how long a compound takes to fall to half its concentration in your blood, and in this family it runs from around eight minutes to around eight days. Our growth hormone guide sets out the range.
At one end, ipamorelin clears in roughly two hours. Everything it does happens inside a narrow window, so the hour you inject is most of the story.
At the other, CJC-1295 with DAC persists for days. There is no hour when it is absent, so there is no hour that is better, and the timing question mostly dissolves. Our comparison of the two forms of CJC-1295 covers why the DAC version behaves so differently.
The same logic separates the weekly GLP-1 drugs from the short-acting compounds. It also explains why some timing advice can be followed at all.
Work out where your compound sits on that range before worrying about the hour, because for some of them the hour is not a real variable.
The growth hormone family, where the advice holds up
Sermorelin, ipamorelin, CJC-1295, tesamorelin and MK-677 all work by prompting your pituitary to release more of your own growth hormone. So anything that governs your natural release also governs what these compounds can achieve.
Two things govern it, and both are measurable.
Night, because that is when the pulse happens
Growth hormone release is concentrated overnight and tied to deep sleep.
In a controlled study of nine healthy adults, plasma growth hormone rose from 0.6 micrograms per litre at 10pm to 25.0 by 1am.[^1] That is a fortyfold rise across three hours, and it is the pulse these compounds are designed to amplify.
Dosing into that window means adding to a rising signal. Dosing at 2pm means adding to a flat one. Nobody has run the trial comparing the two directly, and the mechanism is not ambiguous.
The same study is the reason our guide on alcohol matters here: three drinks in the evening cut that overnight peak by about two thirds.[^1]
Empty stomach, because food suppresses the release
The better-evidenced half, and the part people get partly wrong.
Eating suppresses growth hormone secretion, through a rise in hypothalamic somatostatin, which is the brake on the whole system. In one study, plasma growth hormone fell significantly 45 to 60 minutes after participants drank 75 grams of glucose, then rebounded above baseline at 210 to 240 minutes.[^2]
That effect is not limited to your own natural release. The response to an injected growth hormone secretagogue is also reduced after oral glucose.[^3] That is what carries the food evidence across from your own physiology to a compound you inject.
So the advice to dose away from food has an actual mechanism behind it. The rebound at three to four hours also explains where the fasting windows in community protocols came from, though nobody repeating them cites it.
The part the advice gets wrong
Almost everyone avoiding food before a dose is thinking about carbohydrates.
In a study of eleven healthy adults, peak growth hormone after exercise was 54% lower following a high-fat meal than following a placebo. The high-glucose meal produced a smaller reduction that did not reach statistical significance. Circulating somatostatin was significantly higher after the fat meal than after either the glucose meal or placebo.[^4]
That study looked at exercise-induced release, not at a peptide, and the direction is the opposite of what the community rule assumes. A handful of nuts before bed may do more to blunt a nightly secretagogue than a slice of bread would.
What day should I take my weekly GLP-1?
Semaglutide, tirzepatide and retatrutide are dosed once a week and have half-lives measured in days. There is no hour of the day when they are meaningfully absent.
The day you choose does not change how the drug works, only whether you remember to take it.
The useful version of the advice is to pick a day you can keep, and to place it so the worst of the side effects lands somewhere convenient. If nausea peaks a day or two after your injection, a Thursday shot puts that on a weekend. That is a lifestyle calculation and not a pharmacological one, and it will do more for you than any schedule will.
Our comparison of the three covers what the side effect profile actually looks like.
Where timing is about side effects, not results
For some compounds the question is not when they work best, but when the effects are least disruptive.
Flushing and nausea are common on melanotan II, heaviest in the first weeks. Evening dosing means sleeping through the worst of it, which is the reason for the convention and has nothing to do with pigmentation.
PT-141 acts within hours and is dosed for that window, which makes it the one compound in this category where timing genuinely is the point.
Neither of these is an efficacy argument. Both are practical, and a schedule that implies a mechanism is doing something else.
What time to inject BPC-157 and the rest: no answer exists
No study has compared morning against evening dosing for BPC-157, for TB-500, or for any of the recovery and longevity compounds sold alongside them.
Several schedules circulate for those compounds. Morning on an empty stomach. Split doses twelve hours apart. Before bed for recovery. None has a published comparison behind it, in either direction.
Our guide on why most peptides have no human evidence covers how that absence comes about. A confident timing rule for a compound with no timing study is a rule somebody made up, and the more precise it gets the less it is standing on.
Twice-daily dosing costs more than convenience
Choosing a schedule is also choosing how many injections and how many punctures you commit to.
A twice-daily protocol is fourteen injections a week instead of seven. That doubles the sites you need in rotation, and our guide on where to inject explains why keeping each injection at least a centimetre from the last, in a fixed quadrant order, is what protects the tissue.
It also doubles the punctures through the stopper. Our guide on vial punctures covers what repeated entry does to it, and the short version is that the stopper was validated for four punctures while a twice-daily schedule goes through it around sixty times a month.
Neither of those makes twice-daily dosing wrong. They are costs that belong in the decision, and they are usually invisible when the choice is framed as a question about timing alone.
What to do about a missed or late dose
The answer splits the same way everything else on this page does.
For a weekly drug with a half-life measured in days, a dose a day or two late barely registers. Follow whatever the prescribing information says about spacing, and do not double up to compensate.
For a short-acting nightly compound, a missed night is a missed night. There is no published basis for taking two doses the following day, and doing so puts a larger amount into a system whose response to a larger amount has not been characterised.
For everything else, nobody has studied it, which means the advice circulating about restarting cycles or resetting clocks after a gap is invented.
The general rule across drug classes is to take the missed dose if you remember close to the time and skip it if you are near the next one. That is standard pharmacy guidance, not anything peptide-specific, and nothing about these compounds suggests they need their own version of it.
How to find out for yourself
If your compound is short-acting, timing is a real variable and it is one of the few things on this site you can actually test on yourself.
The method is the same one our guide on how long peptides take to work sets out, applied to a schedule instead of a compound.
Pick one measure before you start, and write down where it sits now. Sleep quality, morning appetite, recovery between sessions, whatever the compound is supposed to affect. Write it down, because memory drifts toward whatever you expect.
Then hold everything else still. Same dose, same site rotation, same compound, and change only the hour. A timing experiment run while you also start a second compound produces nothing.
Give each schedule several weeks. A fortnight is where expectation is strongest and where the least has had time to happen.
And expect the answer to be no difference. No difference is the most likely finding, it is a real result, and it beats following a schedule you never questioned.
This tells you nothing about a lab marker, since you are not measuring one. It tells you about how you feel, which is the outcome most timing advice is really about anyway.
The thing that outweighs all of it
For most compounds and most people, the best time is the one you will actually keep.
A protocol dosed at 3am because a forum said the pulse peaks then is a protocol that gets missed. Adherence is measurable and it moves outcomes in every drug class where anyone has looked, which is more than can be said for the timing rules on this page.
The growth hormone family is the exception worth accommodating, because the physiology is real. Even there, dosing at 11pm consistently beats dosing at 1am occasionally.
What no schedule can settle
Whether one hour genuinely outperforms another for any peptide. The mechanism arguments above are sound and no trial has compared timings head to head.
How long to leave between food and a dose. The rebound timing in the glucose study suggests something, and nobody has tested a specific gap for a specific compound.
Whether splitting a dose across the day helps. That question has not been studied for any research peptide, and the protocols recommending it do not cite anything.
Common questions
Should I take peptides on an empty stomach?
For growth hormone compounds, there is a real reason to. Food raises somatostatin, which suppresses growth hormone release, and the response to an injected secretagogue is reduced after eating.[^2][^3] For other peptides no comparison has been published.
What time of day should I inject BPC-157?
No study has compared times. The schedules circulating have no published basis, so pick one you can keep and stay consistent.
Is it better to take growth hormone peptides at night?
The mechanism supports it. Growth hormone release is concentrated overnight, rising roughly fortyfold between 10pm and 1am in one controlled study.[^1] No trial has compared night against morning dosing for any secretagogue directly.
How long should I wait after eating?
There is no tested answer. Glucose suppressed growth hormone for 45 to 60 minutes in one study, with a rebound at three to four hours.[^2] That range is where the community fasting windows came from, and no study has tested a specific gap for a specific compound.
Does fat or carbohydrate matter more before dosing?
Possibly fat, which is the opposite of what most protocols assume. A high-fat meal reduced peak growth hormone after exercise by 54%, while a high-glucose meal produced a smaller and non-significant reduction.[^4]
Does it matter what day I take my weekly GLP-1?
Not pharmacologically. These drugs have half-lives measured in days, so no day is different. Choose one you will remember, and consider placing it so any nausea lands when you can afford it.
Does the half-life change how much timing matters?
Considerably. A compound clearing in two hours makes the injection hour most of the story. One that persists for days has no hour when it is absent, so there is no better time to choose.
What should I do if I miss a dose?
For a weekly drug, follow the spacing guidance in your prescribing information and do not double up. For a short-acting nightly compound, treat a missed night as missed; there is no published basis for taking two the next day. For everything else nobody has studied it.
Can I test the timing myself?
For a short-acting compound, yes, and it is one of the few things here you can test. Pick one measure, record a baseline, change only the hour, hold the dose and everything else still, and give each schedule several weeks. Expect no difference, which is a real result.
Can I switch my dosing time?
For weekly drugs, yes, following whatever your prescribing information says about spacing. For growth hormone compounds, moving away from an overnight dose means dosing into a flatter natural signal.
Should I split my dose across the day?
Nobody has tested that for any research peptide. Protocols recommending it cite nothing, since there is nothing to cite.
Sources
[^1]: Välimäki M, et al. Ethanol decreases nocturnal plasma levels of thyrotropin and growth hormone. Peer-reviewed study, abstract read at source. Nine healthy subjects. In the control condition, plasma growth hormone rose from 0.6 micrograms per litre at 10pm to 25.0 at 1am. Ethanol at 1.0 g/kg reduced that peak to 4.5 and at 0.5 g/kg to 8.2, both statistically significant. Cited here for the shape of the overnight pulse as well as the alcohol effect.
[^2]: Effects of ingestion of glucose on GH and TSH secretion: evidence for stimulation of somatostatin release from the hypothalamus by acute hyperglycemia in normal man. Peer-reviewed study, abstract read at source. Nine normal subjects. Plasma growth hormone was significantly lowered 45 to 60 minutes after ingestion of 75 grams of glucose, and elevated above baseline at 210 and 240 minutes. The authors conclude that acute hyperglycaemia stimulates somatostatin release from the hypothalamus, inhibiting growth hormone secretion.
[^3]: Sorkina E, et al. The role of glucose and insulin in the metabolic regulation of growth hormone secretion. Peer-reviewed review, read at source. States that in healthy people, growth hormone secretion in response to GHRH or to a growth hormone secretagogue decreases after oral glucose administration. This is the finding that extends the food effect from natural release to an injected compound, and it is the single most relevant citation on this page.
[^4]: Cappon J, et al. Acute effects of high fat and high glucose meals on the growth hormone response to exercise. Peer-reviewed study, abstract read at source. Eleven healthy young adults, 10 minutes of high-intensity cycle ergometry in the morning after an overnight fast, on separate days following a non-caloric placebo, a high-fat or a high-glucose liquid meal, matched for volume and calories. Mean peak post-exercise growth hormone was 54% lower after the high-fat meal than after placebo. The decrease after the high-glucose meal was not statistically significant. Serum somatostatin was significantly higher after the high-fat meal than after either of the others. Measures exercise-induced release rather than secretagogue-induced release, which is a real limitation and is stated in the body.